Marcela Aguilar 4/1/26 Marcela Aguilar 4/1/26 Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles Read More Marcela Aguilar 3/19/26 Marcela Aguilar 3/19/26 The indirect — and sometimes surprising — benefits of vaccines Read More Marcela Aguilar 3/2/26 Marcela Aguilar 3/2/26 Meeting on U.S. Measles Status Is Delayed Until November Read More Marcela Aguilar 2/18/26 Marcela Aguilar 2/18/26 US FDA reverses course, will review Moderna’s flu vaccine application Read More Marcela Aguilar 2/12/26 Marcela Aguilar 2/12/26 The FDA’s Big Shift Read More Marcela Aguilar 2/11/26 Marcela Aguilar 2/11/26 FDA officials defend decision to not review Moderna's new flu vaccine Read More Marcela Aguilar 2/9/26 Marcela Aguilar 2/9/26 What to Know About Measles as the Virus Spreads Read More Marcela Aguilar 2/4/26 Marcela Aguilar 2/4/26 Health Department Will Mine Unverified Vaccine Injury Claims With New AI Tool Read More
Marcela Aguilar 4/1/26 Marcela Aguilar 4/1/26 Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles Read More
Marcela Aguilar 3/19/26 Marcela Aguilar 3/19/26 The indirect — and sometimes surprising — benefits of vaccines Read More
Marcela Aguilar 3/2/26 Marcela Aguilar 3/2/26 Meeting on U.S. Measles Status Is Delayed Until November Read More
Marcela Aguilar 2/18/26 Marcela Aguilar 2/18/26 US FDA reverses course, will review Moderna’s flu vaccine application Read More
Marcela Aguilar 2/11/26 Marcela Aguilar 2/11/26 FDA officials defend decision to not review Moderna's new flu vaccine Read More
Marcela Aguilar 2/9/26 Marcela Aguilar 2/9/26 What to Know About Measles as the Virus Spreads Read More
Marcela Aguilar 2/4/26 Marcela Aguilar 2/4/26 Health Department Will Mine Unverified Vaccine Injury Claims With New AI Tool Read More
